Rosmarin, D
502  results:
Search for persons X
?
 
?
5

Efficacy of in‐class interleukin‐23 inhibitor switching: ri..:

Reddy, R. ; Pannu, S. ; Fiumara, K...
British Journal of Dermatology.  184 (2020)  3 - p. 559-561 , 2020
 
?
6

Risk of connective tissue disease, morphoea and systemic va..:

Schneeweiss, M.C. ; Merola, J.F. ; Schneeweiss, S...
Journal of the European Academy of Dermatology and Venereology.  35 (2020)  1 - p. 195-202 , 2020
 
?
 
?
8

Rebound effect associated with JAK inhibitor use in the tre..:

Gordon, S.C. ; Abudu, M. ; Zancanaro, P...
Journal of the European Academy of Dermatology and Venereology.  33 (2019)  4 - p. , 2019
 
?
9

Improvement of atopic dermatitis with dupilumab occurs equa..:

Blauvelt, A. ; Rosmarin, D. ; Bieber, T....
British Journal of Dermatology.  181 (2019)  1 - p. 196-197 , 2019
 
?
10

The use of JAK inhibitors in the treatment of progressive s..:

Deverapalli, S.C. ; Rosmarin, D.
Journal of the European Academy of Dermatology and Venereology.  32 (2018)  8 - p. , 2018
 
?
 
?
12

GA-binding protein transcription factor: a review of GABP a..:

Rosmarin, A
Blood Cells, Molecules, and Diseases.  32 (2004)  1 - p. 143-154 , 2004
 
?
13

The Scotch Michaelmas Bannock:

Rosmarin
Notes and Queries.  s13-I (1923)  14 - p. 269-269 , 1923
 
?
14

Repigmentation by body region in patients with vitiligo tre..:

Passeron, Thierry ; Harris, John E. ; Pandya, Amit G....
Journal of the European Academy of Dermatology and Venereology.  , 2024
 
?
15

497 - Lebrikizumab in combination with topical corticostero..:

Yosipovitch, Gil ; Lio, Peter A ; Rosmarin, David...
British Journal of Dermatology.  190 (2024)  Supplement_2 - p. ii6-ii7 , 2024
 
1-15